中文 | English
Return
Total: 15 , 1/2
Show Home Prev Next End page: GO
Author:(Michael BERK)

1.Tobacco Use in Bipolar Disorder.

Daniel THOMSON ; Michael BERK ; Seetal DODD ; Marta RAPADO-CASTRO ; Shae E QUIRK ; Pernille K ELLEGAARD ; Lesley BERK ; Olivia M DEAN

Clinical Psychopharmacology and Neuroscience 2015;13(1):1-11

2.Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder.

Sung Wan KIM ; Seetal DODD ; Lesley BERK ; Jayashri KULKARNI ; Anthony DE CASTELLA ; Paul B FITZGERALD ; Jae Min KIM ; Jin Sang YOON ; Michael BERK

Psychiatry Investigation 2015;12(3):349-355

3.Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine Transporter Genetic Variation on Antidepressant Efficacy in Major Depression: A Pilot Study.

Ajeet Bhagat SINGH ; Chad A BOUSMAN ; Chee Hong NG ; Keith BYRON ; Michael BERK

Clinical Psychopharmacology and Neuroscience 2015;13(1):53-61

4.N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review.

Georgina OLIVER ; Olivia DEAN ; David CAMFIELD ; Scott BLAIR-WEST ; Chee NG ; Michael BERK ; Jerome SARRIS

Clinical Psychopharmacology and Neuroscience 2015;13(1):12-24

5.Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress.

Stephen J WOOD ; Murat YÜCEL ; Christos PANTELIS ; Michael BERK

Annals of the Academy of Medicine, Singapore 2009;38(5):396-396

6.Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial.

Olivia May DEAN ; Michael MAES ; Melanie ASHTON ; Lesley BERK ; Buranee KANCHANATAWAN ; Atapol SUGHONDHABIROM ; Sookjareon TANGWONGCHAI ; Chee NG ; Nathan DOWLING ; Gin S MALHI ; Michael BERK

Clinical Psychopharmacology and Neuroscience 2014;12(3):180-188

7.Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment

Gerard ANMELLA ; Alcy MEEHAN ; Melanie ASHTON ; Mohammadreza MOHEBBI ; Giovanna FICO ; Chee H. NG ; Michael MAES ; Lesley BERK ; Michele De PRISCO ; Ajeet B. SINGH ; Gin S. MALHI ; Michael BERK ; Seetal DODD ; Diego HIDALGO-MAZZEI ; Iria GRANDE ; Isabella PACCHIAROTTI ; Andrea MURRU ; Eduard VIETA ; Olivia M. DEAN

Clinical Psychopharmacology and Neuroscience 2024;22(1):33-44

8.Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10

Hedda SOLOEY-NILSEN ; Kristin NYGAARD-ODEH ; Magnhild Gangsoey KRISTIANSEN ; Erling Inge KVIG ; Ole Lars BREKKE ; Tom Eirik MOLLNES ; Michael BERK ; Solveig Klaebo REITAN ; Terje OIESVOLD

Clinical Psychopharmacology and Neuroscience 2024;22(2):285-294

9.Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder.

Izabela G BARBOSA ; Gabriela Neves VAZ ; Natalia Pessoa ROCHA ; Rodrigo MACHADO-VIEIRA ; Marcio Rogerio Diniz VENTURA ; Rodrigo B HUGUET ; Moises E BAUER ; Michael BERK ; Antônio L TEIXEIRA

Clinical Psychopharmacology and Neuroscience 2017;15(3):269-275

10.Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia

Alyna TURNER ; John J MCGRATH ; Olivia M DEAN ; Seetal DODD ; Andrea BAKER ; Susan M COTTON ; James G SCOTT ; Bianca E KAVANAGH ; Melanie M ASHTON ; Adam J WALKER ; Ellie BROWN ; Michael BERK

Clinical Psychopharmacology and Neuroscience 2019;17(2):297-307

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 15 , 1/2 Show Home Prev Next End page: GO